Acute Myeloid Leukemia: Incremental Improvement In Outcome In A Developing Country

摘要

: A retrospective study on Burkitt lymphoma patients was done.The complications encountered and outcomes were retrieved from theelectronic medical records. All patients were treated with MCP 842 pro-tocol except for Group C CNS positive and Group C poor day 8 COP pre-phase response who received LMB protocol with or without rituximab.Patients with poor response post 2 cycles of MCP 842 protocol werecommenced on LMB salvage (LMB-S). Conventional statistics includingunivariate and multivariate techniques was used to analyse the data.